Laddar...
In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology
FDA approval of anti-CTLA4 in 2011 for melanoma immunotherapy was paradigm shifting and dramatically accelerated cancer immunotherapy research. The investment and effort have been exceptionally large, with a commensurate impressive pace of discovery. Historical and current research has validated the...
Sparad:
| I publikationen: | Int J Hyperthermia |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189648/ https://ncbi.nlm.nih.gov/pubmed/33455477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02656736.2020.1810333 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|